Analyst Ratings for Cincor Pharma Inc (CINC) [Buys]
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/28/2022 | Goldman Sachs » Updated 11/29/2022 |
Madhu Kumar | New Coverage | Buy (N/A) |
26.00 (64.00) |
33.97 (29.06) |
-14.45% | Details |
| 8/22/2022 | Piper Sandler » Updated 2/22/2023 |
Yasmeen Rahimi | New Coverage | Overweight (N/A) |
24.00 (33.00) |
35.02 (29.06) |
-17.02% | Details |
 |
||||||||
|
||||||||
